Pertussis antibody levels in infants immunized with an acellular pertussis component vaccine, measured using whole-cell pertussis ELISA

Immunology and Cell Biology

Volumn 78, Issue 3, 2000, Pages 254-258

  Hanlon, Mark G ^a,d   Nambiar, R ^a   Kakakios, A M ^a   McIntyre, P ^b   Land, M V ^c   Devine, P L ^c  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b Natl Ctr for Immunization Res   (Australia)

^c PanBio Australia   (Australia)

^d Senior Hospital Scientist   (Australia)

Author keywords

Acellular vaccine; Enzyme linked immunosorbent assay; Immunoglobulin G; Pertussis

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; IMMUNOGLOBULIN M;

ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; HUMAN; INFANT; MAJOR CLINICAL STUDY; PERTUSSIS; SEROCONVERSION; VACCINATION;

ANTIBODIES, BACTERIAL; BORDETELLA PERTUSSIS; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; INFANT; PERTUSSIS VACCINE; REAGENT KITS, DIAGNOSTIC; WHOOPING COUGH;

EID: 0034047655     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.2000.00910.x     Document Type: Article

References (17)

1. 1 Trollfors B, Taranger J, Lagergärd T et al. A placebo-controlled trial of a pertussis toxoid vaccine. N. Engl. J. Med. 1995; 333: 1045-50.
2. 2 Greco D, Salmaso S, Mastrantonio P et al. A controlled trial of two acellular and one whole-cell vaccine against pertussis. N. Engl. J. Med. 1996; 334: 341-8.
3. 3 Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N. Engl. J. Med. 1996; 334: 349-55.
4. 4 Edwards KM, Meade BD, Decker MD et al. Comparison of 13 acellular pertussis vaccines: Overview and serologic response. Pediatrics 1995; 96 (Suppl.): 548-57.
5. 5 Pichichero ME, Green JL, Francis AB, Marsocci SM, Murphy AM, Buscarino C. Antibody response and reactions to completion of a four-dose series with a two-or three-component acellular pertussis vaccine compared to whole cell pertussis vaccine. Scand. J. Infect. Dis. 1996; 28: 159-63.
6. 6 Black SB, Shinefield HR, Bergen R et al. Safety and immunogenicity of Chiron/Biocine recombinant acellular pertussis-diphtheria-tetanus vaccine in infants and toddlers. Pediatr. Infect. Dis. J. 1997; 16: 53-8.
7. 7 Reizenstein E, Hallander HO, Blackwelder WC, Kuhn I, Ljungman M, Mollby R. Comparison of five calculation modes for antibody ELISA procedures using pertussis serology as a model. J. Immunol. Meth. 1995; 183: 279-90.
8. 8 Cattaneo LA, Reed GW, Haase DH, Wills MJ, Edwards KM. The seroepidemiology of Bordetella pertussis infections: A study of persons ages 1-65 years. J. Infect. Dis. 1996; 173: 1256-9.
9. 9 Andrews R, Herceg A, Roberts C. Pertussis notifications in Australia. 1991-97. Commun. Dis. Intell. 1997; 21: 145-8.
10. 10 Mertsola J, Kuronen T, Turunen A, Viljanen MK, Ruuskanen O. Diagnosis of pertussis. J. Infect. 1984; 8: 149-56.
11. 11 Mertsola J, Ruuskanen O, Kuronen T, Viljanen MK. Serologic diagnosis of pertussis: Comparison of enzyme-linked assay and bacterial agglutination. J. Infect. Dis. 1983; 147: 252-7.
12. 12 Mertsola J, Ruuskanen O, Kuronen T, Meurman O, Viljanen MK. Serologic diagnosis of pertussis: Evaluation of pertussis toxin and other antigens in enzyme-linked immunosorbent assay. J. Infect. Dis. 1990; 161: 966-71.
13. 13 He Q, Mertsola J, Himanen JP, Ruuskanen O, Viljanen MK. Evaluation of pooled and individual components of Bordetella pertussis as antigens in an enzyme immunoassay for diagnosis of pertussis. Eur. J. Clin. Microbiol. Infect. Dis. 1993; 12: 690-5.
14. 14 Englund JA, Anderson EL, Reed GF et al. The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoids. Pediatrics 1995; 96 (Suppl.): 580-4.
15. 15 Giuliano M, Mastrantonio P, Giammanco A, Piscitelli A, Salmaso S, Wassilak SGF. Antibody responses and persistence in the two years after immunization with two acellular vaccines and one-whole-cell vaccine against pertussis. J. Pediatr. 1998; 132: 983-8.
16. 16 Heininger U, Cherry JD, Christenson PD et al. Comparative study of Lederle/Takeda acellular and Lederle whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants in Germany. Vaccine 1994; 12: 81-6.
17. 17 Burstyn DG, Baraff LJ, Peppler MS, Leake RD, St Geme Jr J, Manclark CR. Serological response to filamentous haemagglutinin and lymphocytosis-promoting toxin of Bardetella pertussis. Infect. Immun. 1983; 41: 1150-6.